Stay updated on Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study record now shows a Completed status, with the Primary Completion Date updated to 2026-04-09 and the Study Completion Date updated to 2026-05-08, replacing prior estimated dates. This change clarifies the final timeline of the trial.
    Difference
    0.4%
    Check dated 2026-05-29T07:47:40.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.3 to v3.5.4, indicating a maintenance or content update to the Study Details page. The change does not modify the study data, results, or primary content presented.
    Difference
    0.0%
    Check dated 2026-05-15T06:43:58.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page’s footer revision label has been updated from **v3.5.2** to **v3.5.3**, indicating a minor site release without changing the displayed study record information.
    Difference
    0.0%
    Check dated 2026-04-24T05:54:57.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:29:47.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Added new study details for Nadunolimab in combination with gemcitabine and carboplatin (TRIFOUR), including Phase Ib/II design and updated dates. Removed the prior TRIFOUR entry and related outdated notes.
    Difference
    0.4%
    Check dated 2026-04-09T21:31:40.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    - Revision: v3.5.0 added in the header; the previous version v3.4.3 was removed from the display.
    Difference
    0.0%
    Check dated 2026-03-19T05:08:18.000Z thumbnail image

Stay in the know with updates to Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nadunolimab Combo for Triple Negative Breast Cancer Clinical Trial page.